Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Müller-Spahn

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Neurobiology of Aging|July 11, 2001
Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementiaE Savaskan, C Hock, G Olivieri, et al.
Psychopharmacology|January 1, 1984
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesiaF Müller-Spahn, M Ackenheil, M Albus, et al.
Neuroscience|August 5, 2003
Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatoninG Olivieri, U Otten, F Meier, et al.
Neuroscience Letters|April 18, 1998
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patientsP März, K Heese, C Hock, et al.
Journal of Neurochemistry|January 9, 2001
N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylationG Olivieri, G Baysang, F Meier, et al.
Molecular Psychiatry|October 14, 2000
Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depressionC Hock, K Heese, F Müller-Spahn, et al.
Neurology|May 24, 2000
Increased CSF levels of nerve growth factor in patients with Alzheimer's diseaseC Hock, K Heese, F Müller-Spahn, et al.
Neurology & Clinical Neurophysiology : NCN|May 25, 2002
Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cellsG Olivieri, U Otten, F Meier, et al.
Neuroscience Letters|July 11, 2001
Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's diseaseE Savaskan, G Olivieri, L Brydon, et al.
Der Nervenarzt|May 5, 1998
[The social status of schizophrenic patients]P Müller, W Gaebel, B Bandelow, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Neurobiology of Aging|July 11, 2001
Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementiaE Savaskan, C Hock, G Olivieri, et al.
Psychopharmacology|January 1, 1984
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesiaF Müller-Spahn, M Ackenheil, M Albus, et al.
Neuroscience|August 5, 2003
Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatoninG Olivieri, U Otten, F Meier, et al.
Neuroscience Letters|April 18, 1998
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patientsP März, K Heese, C Hock, et al.
Journal of Neurochemistry|January 9, 2001
N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylationG Olivieri, G Baysang, F Meier, et al.
Molecular Psychiatry|October 14, 2000
Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depressionC Hock, K Heese, F Müller-Spahn, et al.
Neurology|May 24, 2000
Increased CSF levels of nerve growth factor in patients with Alzheimer's diseaseC Hock, K Heese, F Müller-Spahn, et al.
Neurology & Clinical Neurophysiology : NCN|May 25, 2002
Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cellsG Olivieri, U Otten, F Meier, et al.
Neuroscience Letters|July 11, 2001
Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's diseaseE Savaskan, G Olivieri, L Brydon, et al.
Der Nervenarzt|May 5, 1998
[The social status of schizophrenic patients]P Müller, W Gaebel, B Bandelow, et al.
Pageof 10